Frontiers in Pharmacology (Dec 2022)
Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
- Ruixue Guo,
- Ruixue Guo,
- Peipei Wang,
- Peipei Wang,
- Xuejun Zheng,
- Xuejun Zheng,
- Wen Cui,
- Wen Cui,
- Jin Shang,
- Jin Shang,
- Jin Shang,
- Zhanzheng Zhao,
- Zhanzheng Zhao,
- Zhanzheng Zhao
Affiliations
- Ruixue Guo
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Ruixue Guo
- Zhengzhou University, Zhengzhou, China
- Peipei Wang
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Peipei Wang
- Zhengzhou University, Zhengzhou, China
- Xuejun Zheng
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xuejun Zheng
- Zhengzhou University, Zhengzhou, China
- Wen Cui
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Wen Cui
- Zhengzhou University, Zhengzhou, China
- Jin Shang
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Jin Shang
- Nephropathy Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Jin Shang
- Laboratory Animal Platform of Academy of Medical Sciences, Zhengzhou, China
- Zhanzheng Zhao
- Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Zhanzheng Zhao
- Nephropathy Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Zhanzheng Zhao
- Laboratory Animal Platform of Academy of Medical Sciences, Zhengzhou, China
- DOI
- https://doi.org/10.3389/fphar.2022.1074294
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- diabetic nephropathy
- sodium-glucose cotransporter-2 inhibitors
- insulin-like growth factor-1 receptor
- podocyte
- epithelial-mesenchymal transition
